TipRanks
Advertisement
Advertisement
Immunovant price target raised to $45 from $43 at BofA
PremiumThe FlyImmunovant price target raised to $45 from $43 at BofA
2M ago
Immunovant Reaffirmed at Buy as IMVT-1402 Trials Advance; $53 Price Target Maintained
Premium
Ratings
Immunovant Reaffirmed at Buy as IMVT-1402 Trials Advance; $53 Price Target Maintained
2M ago
Immunovant reports Q2 EPS (75c), consensus (61c)
Premium
The Fly
Immunovant reports Q2 EPS (75c), consensus (61c)
2M ago
Immunovant price target raised to $47 from $35 at JPMorgan
PremiumThe FlyImmunovant price target raised to $47 from $35 at JPMorgan
4M ago
Immunovant price target raised to $62 from $44 at Guggenheim
Premium
The Fly
Immunovant price target raised to $62 from $44 at Guggenheim
4M ago
Immunovant price target raised to $30 from $23 at Truist
Premium
The Fly
Immunovant price target raised to $30 from $23 at Truist
4M ago
This Is Why Immunovant Stock (IMVT) Is Up Today
PremiumMarket NewsThis Is Why Immunovant Stock (IMVT) Is Up Today
4M ago
Immunovant rises 25.9%
Premium
The Fly
Immunovant rises 25.9%
5M ago
Immunovant reports Q4 EPS (73c), consensus (63)
Premium
The Fly
Immunovant reports Q4 EPS (73c), consensus (63)
5M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―